Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.34
-21.2 %
$ 8.12 M
Market Cap
-0.22
P/E
PRPH - REVENUE
Revenue PRPH - ProPhase Labs, Inc.
44.4 M
LAST VALUE
-25.07%
2 YEAR CAGR
27.59%
5 YEAR CAGR
5.89%
10 YEAR CAGR